Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mariya Viskovska"'
Autor:
Kevin Song, Mariya Viskovska
Publikováno v:
Biomedicines, Vol 8, Iss 11, p 491 (2020)
Vaccinia viral (VV) vectors are increasingly used in oncolytic virus therapy and vaccine development for cancer and infectious diseases. However, their effectiveness is hindered by the strong anti-viral immune response induced by the viral vector. In
Externí odkaz:
https://doaj.org/article/73d363b7fc2a40719e166b810457f0db
Autor:
Xiaomei Wang, Guowei Wei, Keshav B. Karki, Winnie Chan, Mariya Viskovska, Andrew Williams, Nancy Chang, Haiyan Jiang
Publikováno v:
Cancer Research. 82:6225-6225
Chimeric antigen receptor (CAR) - engineered natural killer (NK) cell therapy has emerged as a promising platform for adoptive immunotherapy for cancer. However, CAR-NK or CAR-T therapy so far has achieved limited efficacy in solid tumors compared wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9616da88798b11592128d3360075ced6
https://doi.org/10.1158/1538-7445.am2022-6225
https://doi.org/10.1158/1538-7445.am2022-6225
Autor:
Winnie M. Chan, Mariya Viskovska, Micaela McArthur, Xue Mary Yu, Wei Liang, Zane Norman, Xiaotong Song, Nancy T. Chang, Haiyan Jiang
Publikováno v:
Cancer Research. 82:3300-3300
Oncolytic virotherapy represents a promising therapeutic strategy for cancers that do not respond well to immune checkpoint inhibitors. Oncolytic viruses (OV) preferentially replicate in and lyse tumor cells, leading to systemic immune stimulation. S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb75383ef7d6fbb9431e0b80f3ba11c2
https://doi.org/10.1158/1538-7445.am2022-3300
https://doi.org/10.1158/1538-7445.am2022-3300
Autor:
Mariya Viskovska, Kevin Song
Publikováno v:
Biomedicines
Biomedicines, Vol 8, Iss 491, p 491 (2020)
Biomedicines, Vol 8, Iss 491, p 491 (2020)
Vaccinia viral (VV) vectors are increasingly used in oncolytic virus therapy and vaccine development for cancer and infectious diseases. However, their effectiveness is hindered by the strong anti-viral immune response induced by the viral vector. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eef1d2581fa709d0f92ce01e9e37b5d
http://europepmc.org/articles/PMC7697509
http://europepmc.org/articles/PMC7697509